- Home
- JTAI vs AEON Comparison
JTAI vs AEON Comparison
Compare JTAI & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- AEON
- Stock Information
- Founded
- JTAI 2018
- AEON N/A
- Country
- JTAI United States
- AEON United States
- Employees
- JTAI N/A
- AEON N/A
- Industry
- JTAI Blank Checks
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- JTAI Finance
- AEON Health Care
- Exchange
- JTAI Nasdaq
- AEON Nasdaq
- Market Cap
- JTAI 9.9M
- AEON 8.0M
- IPO Year
- JTAI N/A
- AEON N/A
- Fundamental
- Price
- JTAI $3.70
- AEON $0.85
- Analyst Decision
- JTAI
- AEON Strong Buy
- Analyst Count
- JTAI 0
- AEON 1
- Target Price
- JTAI N/A
- AEON $360.00
- AVG Volume (30 Days)
- JTAI 208.7K
- AEON 247.2K
- Earning Date
- JTAI 08-13-2025
- AEON 08-11-2025
- Dividend Yield
- JTAI N/A
- AEON N/A
- EPS Growth
- JTAI N/A
- AEON N/A
- EPS
- JTAI N/A
- AEON 117.22
- Revenue
- JTAI $13,648,668.00
- AEON N/A
- Revenue This Year
- JTAI $13.37
- AEON N/A
- Revenue Next Year
- JTAI $201.13
- AEON N/A
- P/E Ratio
- JTAI N/A
- AEON $0.01
- Revenue Growth
- JTAI N/A
- AEON N/A
- 52 Week Low
- JTAI $2.30
- AEON $0.38
- 52 Week High
- JTAI $97.40
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- JTAI 49.53
- AEON 58.93
- Support Level
- JTAI $3.33
- AEON $0.80
- Resistance Level
- JTAI $3.75
- AEON $0.86
- Average True Range (ATR)
- JTAI 0.21
- AEON 0.06
- MACD
- JTAI 0.03
- AEON 0.00
- Stochastic Oscillator
- JTAI 59.68
- AEON 75.15
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.